Literature DB >> 18020975

Targeting platelets for prevention and treatment of cardiovascular disease.

Todd A Duhamel1, Yan-Jun Xu, Amarjit S Arneja, Naranjan S Dhalla.   

Abstract

Platelets play an important role in the development of thrombosis, atherosclerosis, hypertension, heart attack and stroke. As a result, pharmacologic interventions that influence platelet functions, such as adhesion, aggregation and the release of different factors, are considered useful for the prevention and treatment of cardiovascular disease. Although classical anti-platelet agents have proven beneficial effects for the treatment of some specific cardiovascular diseases, there are limitations for their use as these drugs target platelet function directly. In contrast, newly developed anti-platelet agents have broad applications for the treatment of cardiovascular disease as they not only influence platelet function but are also considered to affect cardiac and vascular smooth muscle cell functions. Natural food products and nutraceutical agents also appear to modify cardiovascular abnormalities by affecting various platelet functions; however, the mechanisms of their actions remain to be investigated. Accordingly, this article is focused to discuss emerging pharmacologic, nutritional and nutraceutical interventions that may influence the prevention or progression of a broad range of cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18020975     DOI: 10.1517/14728222.11.12.1523

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  8 in total

Review 1.  Prevention of diabetes-induced cardiovascular complications upon treatment with antioxidants.

Authors:  Yan-Jun Xu; Paramjit S Tappia; Nirankar S Neki; Naranjan S Dhalla
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

2.  Central aortic pulse pressure, thrombogenicity and cardiovascular risk.

Authors:  Gailing Chen; Kevin P Bliden; Rahul Chaudhary; Fang Liu; Himabindu Kaza; Eliano P Navarese; Udaya S Tantry; Paul A Gurbel
Journal:  J Thromb Thrombolysis       Date:  2017-08       Impact factor: 2.300

3.  Suppression of high lipid diet induced by atherosclerosis sarpogrelate.

Authors:  Yan-Jun Xu; Ming Zhang; Lei Ji; Vijayan Elimban; Li Chen; Naranjan S Dhalla
Journal:  J Cell Mol Med       Date:  2012-10       Impact factor: 5.310

4.  A randomised controlled trial comparing a dietary antiplatelet, the water-soluble tomato extract Fruitflow, with 75 mg aspirin in healthy subjects.

Authors:  N O'Kennedy; L Crosbie; H-J Song; X Zhang; G Horgan; A K Duttaroy
Journal:  Eur J Clin Nutr       Date:  2016-11-23       Impact factor: 4.016

Review 5.  Fruitflow®: the first European Food Safety Authority-approved natural cardio-protective functional ingredient.

Authors:  Niamh O'Kennedy; Daniel Raederstorff; Asim K Duttaroy
Journal:  Eur J Nutr       Date:  2016-07-07       Impact factor: 5.614

6.  The formyl peptide fMLF primes platelet activation and augments thrombus formation.

Authors:  Maryam F Salamah; Divyashree Ravishankar; Rajendran Vaiyapuri; Leonardo A Moraes; Ketan Patel; Mauro Perretti; Jonathan M Gibbins; Sakthivel Vaiyapuri
Journal:  J Thromb Haemost       Date:  2019-05-24       Impact factor: 5.824

Review 7.  Role of Gut Microbiota and Their Metabolites on Atherosclerosis, Hypertension and Human Blood Platelet Function: A Review.

Authors:  Asim K Duttaroy
Journal:  Nutrients       Date:  2021-01-03       Impact factor: 5.717

8.  Fruitflow inhibits platelet function by suppressing Akt/GSK3β, Syk/PLCγ2 and p38 MAPK phosphorylation in collagen-stimulated platelets.

Authors:  Huilian Chen; Shenghao Zhang; Hui Wang; Li Bao; Wei Wu; Ruomei Qi
Journal:  BMC Complement Med Ther       Date:  2022-03-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.